Global health and global governance of emerging biomedical technologies
Bibliographic Data
| ID | 21514795 |
|---|---|
| Authors | Bryan Cwik (0000-0002-5570-3403, Portland State University, corresponding author) |
| Year | 2023 |
| Volume | 49 |
| Issue | 10 |
| Pages | 719-720 |
| Publication date | 2023-10-01 |
| Open Access | No |
| Type | ARTICLE |
| Venue | Journal of Medical Ethics (JOURNAL) |
| Journal identifiers | ISSN: 0306-6800 • E-ISSN: 1473-4257 |
| Publisher | BMJ (PUBLISHER • GB) |
| DOI | 10.1136/jme-2022-108673 |
| PMID | 36750323 |
| OpenAlex | W4319343379 |
| Language | EN |
| References cited | 5 |
Global governance of emerging, disruptive biomedical technologies presents a multitude of ethical problems. The recent paper by Shozi et al raises some of these problems in the context of a discussion of what could be the most disruptive (and most morally fraught) emerging biomedical technology—human germline genome editing. At the heart of their argument is the claim that, for something like gene editing, there is likely to be tension between the interests of specific states in crafting regulation for the technology, and disagreement about what would be necessary to meet the requirements for responsible translation of gene editing into the clinic. This complicates hopes for a tidy, algorithmic process of crafting global governance via frameworks for regulation built around core ‘ethical values and principles’ (as they are called in the WHO Framework), and also forces us to confront deeper philosophical questions about biotechnology and global health
Bioethics · Biology · Corporate governance · Economics · Emerging technologies · Engineering ethics · Environmental ethics · Genome · Genome editing · Global governance · Management · Political science · Public relations · Sociology · Biomedical Ethics and Regulation · Computer Science · CRISPR and Genetic Engineering · Engineering · Law · Neuroethics, Human Enhancement, Biomedical Innovations · Artificial Intelligence
| Highly cited | No |
|---|